Canada signs deals with Pfizer, Moderna for supply of COVID-19 vaccines
Moderna to provide its mRNA-1273 vaccine candidate while Pfizer- BioNTech to supply their BNT162 mRNA-based vaccine candidate
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BNT162 mRNA-based vaccine
Pfizer and BioNTech sign deal with Japan for 120 mn doses of mRNA-based COVID-19 vaccine
The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October…